- | Country :
- Finland
- Germany
- Switzerland
- The 13 others...
- | organs : -
- | Specialty : -
Extract
This is a 12 week study in which different doses of UK-369,003 will be administered to patients with a diagnosis of overactive bladder. Patients will complete a series of questionnaires before treatment, during treatment and after treatment, to assess whether UK-369,003 has improved their symptoms of overactive bladder and erectile function.
Inclusion criteria
- Urinary Bladder, Overactive